Better Healthcare For All
TASK is a leading multinational clinical research institute (CRI) committed to accelerating the development of new medicines, vaccines, and diagnostics. With a focus on efficient, high-quality clinical research, TASK provides comprehensive services for sponsors and CROs, spanning Phase I to IV trials across various therapeutic areas.
TASK's global reach extends from its dedicated Phase I unit in Utrecht, Netherlands, in collaboration with UMC Utrecht, to its strategically located clinical sites in Western Cape, South Africa. Located at Primary: 187 - 189 Voortrekker Rd, Cape Town, Western Cape 7500, ZA, TASK also operates from 1 De Lange Street, Belville, Cape Town, Western Cape 7530, ZA; Mike Pienaar Boulevard, Belville, Cape Town, Western Cape 7530, ZA; 1 Stanbery Street, Brooklyn, Cape Town, Western Cape 7405, ZA; 1 Small Street, Belville, Cape Town, Western Cape 7530, ZA; Delft Main Road, Delft, Cape Town, Western Cape 7100, ZA; and 4 Victoria Street, George, Western Cape 6529, ZA. This expansive network enables TASK to offer cost-effective and time-conscious trials, delivering accurate data for its partners.
Since 2005, TASK has successfully completed over 100 projects, collaborating with leading international sponsors, CROs, and consortiums. As a partner in the largest Tuberculosis (TB) consortium globally, TASK is dedicated to developing a new TB treatment regimen. We invite the management of TASK to create a customized and exclusive company showcase and product listing on our platform to further highlight your exceptional capabilities.
TASK est un institut multinational de recherche clinique (IRC) de premier plan, engagé à accélérer le développement de nouveaux médicaments, vaccins et diagnostics. En mettant l'accent sur une recherche clinique efficace et de haute qualité, TASK fournit des services complets aux commanditaires et aux ORC, couvrant les essais de phase I à IV dans divers domaines thérapeutiques.
La portée mondiale de TASK s'étend de son unité de phase I dédiée à Utrecht, aux Pays-Bas, en collaboration avec UMC Utrecht, à ses sites cliniques stratégiquement situés au Cap-Occidental, en Afrique du Sud. Situé à Primary: 187 - 189 Voortrekker Rd, Cape Town, Western Cape 7500, ZA, TASK opère également à partir de 1 De Lange Street, Belville, Cape Town, Western Cape 7530, ZA; Mike Pienaar Boulevard, Belville, Cape Town, Western Cape 7530, ZA; 1 Stanbery Street, Brooklyn, Cape Town, Western Cape 7405, ZA; 1 Small Street, Belville, Cape Town, Western Cape 7530, ZA; Delft Main Road, Delft, Cape Town, Western Cape 7100, ZA; et 4 Victoria Street, George, Cape Western 6529, ZA. Ce vaste réseau permet à TASK de proposer des essais rentables et rapides, fournissant des données précises à ses partenaires.
Depuis 2005, TASK a réalisé avec succès plus de 100 projets, en collaborant avec les principaux commanditaires internationaux, les ORC et les consortiums. En tant que partenaire du plus grand consortium mondial de lutte contre la tuberculose (TB), TASK se consacre au développement d'un nouveau schéma thérapeutique contre la TB. Nous invitons la direction de TASK à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin de mettre en évidence davantage vos capacités exceptionnelles.
Compare TASK with 3 companies in Research
| Comparison Field |
TASKMain Company |
St. Jude Children's...View Profile |
Acumen Research Labo...View Profile |
Vitaly Clinical Rese...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 0 | 2023 | |
|
Company Size
|
— | 5,001-10,000 | 11-50 | |
|
City
|
Cape Town, Western Cape | Memphis, Tennessee | Miami, Florida | |
|
Country
|
South Africa | United States | United States | |
|
Skills & Keywords
Comparing with main company
|
20 Total Skills
Clinical Research
Clinical Trials
Pharmaceutical Research
Vaccine Development
Medical Diagnostics
Phase I Trials
Phase IV Trials
Tuberculosis
phase III studies
CRO services
laboratory diagnostics
data management
clinical trials
phase IV studies
clinical research
good clinical practice education
clinical pharmacy
sponsor services
phase I studies
infectious diseases
|
15 Total
15 Unique
Unique Skills:
basic science
blood disorders
cancer
cancer research
cancer survivorship
childhood cancer
+9
|
6 Total
6 Unique
Unique Skills:
assay development
biomarkers
cancer
innovation & clinical development of technology
Molecular diagnostics
PCR
|
15 Total
15 Unique
Unique Skills:
academic collaborations
disease prevention research
ethical research practices
healthcare innovation
medical advisory services
medical ethics
+9
|
Other organizations in the same industry
This company is also known as